Glenmark to Sell Blood-Pressure Drug in the US Market

Mumbai based Glenmark Pharmaceuticals has started exporting to the US, the chemical equivalent of fosinopril sodium oral tablets used to lower blood pressure and treat congestive heart failure.

Glenmark Pharmaceuticals Inc, a wholly owned subsidiary of the company, has commenced shipment of its generic fosinopril sodium oral tablets or Monopril, the company told the Bombay Stock Exchange.

Glenmark is marketing the product through an exclusive license agreement with Invagen Inc, a New York based firm. Invagen filed the Abbreviated New Drug Application (ANDA) and obtained approval from the US Food and Drug Administration for the fosinopril sodium product in April 2005.

As per the agreement, Invagen is responsible for the manufacture and supply of the product while Glenmark has exclusive sales and marketing rights.